Transplant surgeons' perspective on antimicrobial stewardship: Experience with TransQIP

Transpl Infect Dis. 2022 Oct;24(5):e13950. doi: 10.1111/tid.13950.

Abstract

Antimicrobial stewardship programs (ASPs) have been shown to reduce the rates of antimicrobial resistance and improve morbidity and mortality in surgical patients. ASPs have largely been underutilized in solid organ transplant programs, and the current state of ASPs in transplantation is reviewed. Continued implementation of ASPs would likely significantly benefit transplant patients. Furthermore, coupling ASPs with robust programmatic metrics (such as transplant-specific NSQIP) will hopefully lead to improved outcomes including morbidity and mortality of solid organ transplant recipients.

Keywords: Clostridioides difficile; organ transplant outcomes; surgical Quality.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Stewardship*
  • Humans
  • Organ Transplantation*
  • Surgeons*
  • Transplant Recipients

Substances

  • Anti-Bacterial Agents